tovorafenib 300 MG Powder for Oral Suspension

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

tovorafenib 300 MG Powder for Oral Suspension

300 MG · Powder for Oral Suspension · oral

A form of tovorafenib →

tovorafenib 300 MG Powder for Oral Suspension — B-Raf serine-threonine kinase (BRAF) inhibitors. Strength, form, class, interactions & more.

tovorafenib 300 MG Powder for Oral Suspension

Active ingredient

Classification

B-Raf serine-threonine kinase (BRAF) inhibitorsKinase Inhibitor

Drug interactions

Tovorafenib has several drug interactions that may affect its efficacy and safety.

  • majorstrong or moderate CYP2C8 inhibitors — increased risk of adverse reactions
  • majorstrong or moderate CYP2C8 inducers — reduced effectiveness of OJEMDA
  • majorhormonal contraceptives — risk of contraceptive failure and/or increased breakthrough bleeding
  • majorcertain CYP3A substrates — serious therapeutic failures

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.